A
SUPN icon

AlphaQuest’s Supernus Pharmaceuticals SUPN Stock Holding History

AlphaQuest’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,870
Closed -$1.24M – 1831
2025
Q4 		$1.24M Sell
24,870
-966
-4% -$47K 0.07% 347
2025
Q3 		$1.23M Buy
25,836
+3,445
+15% +$139K 0.08% 347
2025
Q2 		$706K Buy
22,391
+17,523
+360% +$562K 0.07% 448
2025
Q1 		$159K Buy
4,868
+1,008
+26% +$35.7K 0.02% 1093
2024
Q4 		$140K Sell
3,860
-3,869
-50% -$136K 0.02% 996
2024
Q3 		$241K Buy
+7,729
New +$241K 0.02% 988

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaQuest's SUPN Position: Q1 2026 in Review

AlphaQuest sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 24,870 shares — an estimated $1.24M sold.

AlphaQuest first reported a position in SUPN in Q3 2024 and held it in 6 quarters. The position peaked at $1.24M in Q4 2025. 328 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • AlphaQuest reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 24,870 Supernus Pharmaceuticals shares in Q1 2026, an estimated $1.24M.
  • AlphaQuest first reported a position in Supernus Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • AlphaQuest's Supernus Pharmaceuticals position peaked at $1.24M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.